Cell Banking: Manufacturing, Testing, Characterization, And Release

Cell banking is a crucial process in advanced therapies, involving the manufacturing, testing, characterizing, and releasing of cells for use in treatments. WuXi Advanced Therapies, a leading CDMO, offers comprehensive technology platforms and services to expedite the discovery, development, testing, manufacturing, and commercialization of clients' pipeline. Our integrated manufacturing and testing services include the production of cell banks and the necessary testing for regulatory documentation. With over 20 years of cGMP cell banking experience and a proven track record, our team is well-equipped to optimize the final product in the shortest possible timeline.

The team at WuXi Advanced Therapies has extensive expertise in manufacturing and releasing cell banks for various cell types. We can assist in demonstrating and documenting the viability, growth, biosafety, and genetic characterization of cells, providing a QA-approved Certificate of Analysis. Additionally, we offer guidance, manufacturing, and testing support for research, working, master, or end of production cell banks, ensuring compliance with regulatory guidelines. The team also collaborates with clients to optimize cell growth and expansion plans, scaling production accordingly.

Located at the Navy Yard campus in Philadelphia, Pennsylvania, our U.S. facilities encompass a cell banking facility, late phase/commercial viral manufacturing and testing, a state-of-the-art integrated testing laboratory, non-viral cell therapy manufacturing, and early phase clinical manufacturing and testing. With audited quality systems, dedicated project managers, and a range of cell culture platforms, WuXi Advanced Therapies is committed to providing efficient and reliable cell banking services to meet clients' needs.